Personalized Medicine in Anesthesia, Pain and Perioperative Medicine 2020
DOI: 10.1007/978-3-030-53525-4_3
|View full text |Cite
|
Sign up to set email alerts
|

Personalized Anesthetic Pharmacology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 61 publications
0
4
0
Order By: Relevance
“…Pharmacogenomics (PGx) is the discipline of predicting drug efficacy and toxicity at the genetic level ( 7 ), dedicated to elucidating the genetic variations that underlie the pharmacodynamics and pharmacokinetics of legacy drugs. This knowledge can guide the clinical selection of optimal therapeutic agents at the most appropriate dosage, improving drug efficacy, reducing or avoiding adverse effects, enhancing prognosis, and saving healthcare costs ( 8 ).…”
Section: Genetic Factorsmentioning
confidence: 99%
See 1 more Smart Citation
“…Pharmacogenomics (PGx) is the discipline of predicting drug efficacy and toxicity at the genetic level ( 7 ), dedicated to elucidating the genetic variations that underlie the pharmacodynamics and pharmacokinetics of legacy drugs. This knowledge can guide the clinical selection of optimal therapeutic agents at the most appropriate dosage, improving drug efficacy, reducing or avoiding adverse effects, enhancing prognosis, and saving healthcare costs ( 8 ).…”
Section: Genetic Factorsmentioning
confidence: 99%
“…Propofol is the most commonly used parenteral anesthetic with sedative-hypnotic, anxiolytic, anticonvulsant, anti-inflammatory, antiemetic, antioxidant, and possibly neuroprotective effects. Differential responses to propofol may be due to polymorphisms in the gene encoding the metabolic enzyme CYP2B6 ( 7 ). Up to 70% of propofol binds to glucuronide via UGT1A9, while the remaining 30% of the drug is first hydroxylated via CYP2B6 ( 17 ).…”
Section: Genetic Factorsmentioning
confidence: 99%
“…Although not commonly prescribed for OA patients, opioid analgesics are a group of drugs most commonly associated with genetic polymorphisms. Tramadol, codeine, and oxycodone are all metabolized by CYP2D6 in the liver and bind to the opioid receptor, both of which have demonstrated the ability to impact the effects and side-effect profile of the drugs [ 49 ]. Another enzyme linked to the effect of opioid analgesics is catechol-O-methyltransferase, which degrades endogenous catecholamines.…”
Section: Peroral Treatmentmentioning
confidence: 99%
“…Another enzyme linked to the effect of opioid analgesics is catechol-O-methyltransferase, which degrades endogenous catecholamines. Its polymorphisms affect the analgesic efficacy of an opioid drug [ 49 ].…”
Section: Peroral Treatmentmentioning
confidence: 99%